Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Enhancement of immune responses to an HBV DNA vaccine by electroporation.

Luxembourg A, Hannaman D, Ellefsen B, Nakamura G, Bernard R.

Vaccine. 2006 May 22;24(21):4490-3. Epub 2005 Aug 19.

PMID:
16140436
2.

Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation.

Peng JL, Zhao YG, Mai JH, Pang WK, Guo W, Chen GM, Mo GY, Rao GR, Xu YH.

Acta Pharmacol Sin. 2007 Jul;28(7):1024-30.

3.
4.

A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.

Li X, Yang X, Li L, Liu H, Liu J.

Vaccine. 2006 Apr 12;24(16):3321-31. Epub 2006 Jan 19.

PMID:
16472546
5.

Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.

Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.

J Virol Methods. 2008 Nov;153(2):142-8. doi: 10.1016/j.jviromet.2008.07.013. Epub 2008 Sep 3.

PMID:
18722475
6.

A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.

Li X, Yang X, Jiang Y, Liu J.

Int Immunol. 2005 Oct;17(10):1293-302. Epub 2005 Aug 19.

PMID:
16113237
7.

[Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice].

Jin YW, Li P, Xu QB, Liu X, Huang W, Wang YL, Cao C, Ma QJ.

Sheng Wu Gong Cheng Xue Bao. 2005 Sep;21(5):681-5. Chinese.

PMID:
16285504
8.

Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Bréchot C, Pol S, Michel ML.

Vaccine. 2006 May 22;24(21):4482-9. Epub 2005 Aug 18.

PMID:
16310901
9.

Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccination.

Zhao YG, Peng B, Deng H, Chen G, Yang F, Shao M, Lu H, Li Y, Peng J, Xu L, Xu Y.

Vaccine. 2006 Feb 13;24(7):897-903. Epub 2005 Sep 12.

PMID:
16253404
10.

The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.

Xing Y, Huang Z, Lin Y, Li J, Chou TH, Lu S, Wang S.

Vaccine. 2008 Sep 19;26(40):5145-52. doi: 10.1016/j.vaccine.2008.03.072. Epub 2008 Apr 18.

PMID:
18462847
11.

DNA vaccines for prophylactic or therapeutic immunization against hepatitis B virus.

Davis HL.

Mt Sinai J Med. 1999 Mar;66(2):84-90. Review.

PMID:
10100411
12.

Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.

Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X.

J Virol Methods. 2007 Apr;141(1):41-8. Epub 2007 Jan 2. Erratum in: J Virol Methods. 2007 Sep;144(1-2):172.

PMID:
17197041
13.

[Induction of immune responses in mice by hepatitis B virus large envelope DNA vaccine delivered by attenuated Salmonella typhimurium].

Zhao P, Wang HW, Lu Y, Qi ZT.

Sheng Wu Gong Cheng Xue Bao. 2002 Sep;18(5):601-4. Chinese.

PMID:
12561207
14.

[HBV DNA vaccination with electroporation enhances significantly the specific cell-mediated immune response in mice against HBV protein vaccine consisting of S-PreS1 fusion particles].

Chen H, Zhang LL, Tan WJ, Deng Y, Wang W, Yin X, Wen B, Guan J, Ruan L.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Apr;24(2):94-7. Chinese.

PMID:
21110423
15.

Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.

Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Bréchot C, Michel ML.

Hepatology. 2004 Oct;40(4):874-82.

PMID:
15382173
16.

Short noncoding DNA fragments improve the immune potency of electroporation-mediated HBV DNA vaccination.

Peng J, Shi S, Yang Z, Ding Q, Hai W, Tang H, Yang Y, Bernstein JR, Peyda P, Xu Y.

Gene Ther. 2014 Jul;21(7):703-8. doi: 10.1038/gt.2014.44. Epub 2014 May 15.

PMID:
24830435
17.

Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.

Liu KH, Ascenzi MA, Bellezza CA, Bezuidenhout AJ, Cote PJ, Gonzalez-Aseguinolaza G, Hannaman D, Luxembourg A, Evans CF, Tennant BC, Menne S.

J Virol. 2011 May;85(10):4853-62. doi: 10.1128/JVI.02437-10. Epub 2011 Mar 9.

18.

[Construction of a recombinant HBV DNA vaccine and its evaluation for specific cellular immune response in mice].

Guo Y, Wang JF, Luo XC, Su J, Ma L, Zhang YD.

Nan Fang Yi Ke Da Xue Xue Bao. 2006 Dec;26(12):1803-5. Chinese.

19.

DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?

Beckebaum S, Cicinnati VR, Gerken G.

Rev Med Virol. 2002 Sep-Oct;12(5):297-319. Review.

PMID:
12211043
20.

Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.

Yan J, Liu X, Wang Y, Jiang X, Liu H, Wang M, Zhu X, Wu M, Tien P.

J Gene Med. 2007 Feb;9(2):107-21.

PMID:
17256801

Supplemental Content

Support Center